FDA
approval
· 2018-04-09
FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Mylan Pharmaceuticals Inc.)
Summary
The FDA approved the original application for a generic fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, manufactured by Mylan Pharmac…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)